Oncolytics Biotech (ONCY) Tops Q1 Loss Views by 3c
Tweet
Share
E-mailGet Alerts ONCY Hot Sheet
Join SI Premium – FREE
Oncolytics Biotech (NASDAQ: ONCY) reported Q1 loss of ($0.06), $0.03 better than the analyst estimate of ($0.09).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Smith & Wesson Brands (SWBI) Tops Q4 EPS by 15c
- La-Z-Boy (LZB) Tops Q4 EPS by 44c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
